<PAGE>
This filing is made pursuant
to Rule 424 (b)(3) under
the Securities Act of 1933
in connection with
Registration No. 333-69725
SUPPLEMENT TO PROSPECTUS DATED JANUARY 8, 1999
931,373 SHARES
HOLLIS-EDEN PHARMACEUTICALS, INC.
Common Stock
---------------------
The Prospectus dated January 8, 1999 is hereby supplemented as follows to
restate, in its entirety, the "Selling Stockholders" section on page 11 of the
Prospectus:
SELLING STOCKHOLDERS
The following table sets forth the names of the Selling Stockholders
and the number of shares of Common Stock owned beneficially by them as of March
17, 1999 which may be offered pursuant to this Prospectus. This information is
based upon information provided by each selling stockholder. Because the Selling
Stockholders may offer all, some or none of their respective shares of Common
Stock, no definitive estimate as to the number of shares thereof that will be
held by the Selling Stockholders after such offering can be provided. The term
"Selling Stockholder" includes the holders listed below and their transferees,
pledgees, donees or other successors.
Name Shares Being Offered(1)
----- -----------------------
MDB Capital ................................... 316,981
LHIP Acquisition Company ...................... 52,400
J. Paul Bagley (2) ............................ 57,580
Victor K. Atkins .............................. 7,511
John A. Tommasini ............................. 6,259
Douglas Miscoll ............................... 5,007
John D. McKey, Jr ............................. 2,503
Candace McKey ................................. 2,503
Mary Jochim ................................... 1,252
LHIP Management Company L.L.C ................. 834
International Investor Relations Group ........ 3,493
Boniface Costa ................................ 22,222
Growth Ventures, Inc. Pension Plan and Trust... 189,938
Earnest Mathis ................................ 99,999
Leonard Rothstein ............................. 49,999
Jodi P. Rothstein Trust dated 10/7/1998 ....... 50,000
B. A. Bates ................................... 20,964
Underwood Family Partners ..................... 20,964
Brennan, Bromberg, & Tenenbaum P.C ............ 20,964
--------
Total ................................ 931,373
========
___________________
(1) Includes 927,880 shares of common stock issuable upon the exercise of
certain warrants.
(2) J. Paul Bagley is a director of the Company.
Except as set forth above, none of the selling stockholders has, or within the
past three years has had, any position, office or other material relationship
with Hollis-Eden or any of its predecessors or affiliates.
The date of this Prospectus Supplement is September 27, 2000
